HomeNews & TopicsHealth Care PolicyFederal government risks ignoring existing provincial drug insurance plans in push for...

Federal government risks ignoring existing provincial drug insurance plans in push for national program

Published on

New study from the Fraser Institute

Despite widespread misperceptions, every province already provides prescription drug coverage to help Canadians—particularly seniors and lower-income Canadians—pay for pharmaceuticals, finds a new study released today by the Fraser Institute, an independent, non-partisan Canadian public policy think-tank.

“Much of the discussion about a possible national pharmacare plan seemingly assumes there’s no existing government help for Canadians to pay for medicines they need—but that’s just not true,” says Bacchus Barua, associate director of health policy studies at the Fraser Institute and co-author of Provincial Drug Coverage for Vulnerable Canadians.

The study summarizes provincial drug programs across the country and finds that, while levels of coverage vary by province, three key vulnerable groups, namely lower-income Canadians, seniors, and Canadians on social assistance have access to prescription drugs, paid in full or in part by provincial governments.

Provincial governments across Canada also provide drug coverage to select populations who may face considerable hardships as a result of either their medical care costs or other factors including the severely disabled and those diagnosed with conditions like multiple sclerosis and cystic fibrosis.

Crucially, provinces are able to establish prescription drug plans to suit their particular priorities, population age, income levels and other factors, which differ from province to province. This customization would likely be lost or at least diluted if Canada adopts a national program.

Health-care costs for typical Canadian family hit nearly $13,000 this year

“Provinces can tailor drug plans to suit their individual needs, but a single-payer national pharmacare system would put an end to that,” says Yanick Labrie, a senior fellow with the Fraser Institute who specializes in health and pharmaceutical economics.

“Instead of a drug program modelled on our inflexible health-care system, we should instead seek to understand what gaps exist in our provincial plans and target resources to Canadians who need assistance.”

Latest articles

Can mRNA Vaccines Help Treat Pancreatic Cancer?

Pancreatic cancer remains one of the most difficult cancers to treat. It is often...

How AI is transforming patient care in Canada—before the first visit

HN Summary • New study reveals most Canadians don’t turn to AI for mental health...

Improving Patient Experience Starts with How Teams Communicate

Healthcare teams are being asked to do more with less. Staffing shortages, rising patient...

Still managing fax referrals manually?

Despite decades of digital transformation initiatives, one technology still dominates referral intake across hospitals...

More like this

How Health Care Leaders Can Build a Robust AI Risk Management Framework

Artificial intelligence is rapidly moving from pilot projects to enterprise-wide deployment in health care....

Growing pressures facing hospital sector

At recent  2026/27 Pre-Budget Consultations, held by the Ministry of Finance in North York,...

Reporting saves lives: Pushing for safer, more transparent hospitals

HN Summary • Unintended harm remains a serious challenge, affecting 1 in 17 hospitalizations—about 153,000...

Canadian doctors call on Ontario government to reconsider new residency policy

The Canadian Medical Association and the College of Family Physicians of Canada are adding...

Canada needs coordinated primary care – now

We must strengthen the primary care foundation while building an integrated health system –...

Researchers launch intersex health communication guide

The new resource sets a national standard for inclusive, patient-centred care Researchers at McGill’s Centre...